News

Published on 8 Apr 2024 on Simply Wall St. via Yahoo Finance

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)


Article preview image

Key Insights

The projected fair value for Stryker is US$343 based on 2 Stage Free Cash Flow to EquityWith US$351 share price, Stryker appears to be trading close to its estimated fair value The US$361 analyst price target for SYK is 5.1% more than our estimate of fair value

How far off is Stryker Corporation (NYSE:SYK) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine.

NYSE.SYK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?

The first-quarter earnings season is almost at its middle, with several medical device companies ...

Zacks via Yahoo Finance 29 Apr 2024

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1...

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. ...

Benzinga 29 Apr 2024

Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings

Stryker Corporation SYK is scheduled to release first-quarter 2024 results on Apr 30, after marke...

Zacks via Yahoo Finance 24 Apr 2024

What Makes Stryker Corporation (SYK) an Investment Choice?

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 24 Apr 2024

Stryker shares receive positive stance, Outperform rating By Investing.com

On Monday, Evercore ISI maintained a positive stance on Stryker Corporation (NYSE:SYK), a medical...

Investing.com 22 Apr 2024

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Medtronic plc MDT is likely to grow in the coming quarters, backed by remarkable progress within ...

Zacks via Yahoo Finance 18 Apr 2024

Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay

Henry Schein HSIC is well-positioned to gain from its extensive global foothold and diverse chann...

Zacks via Yahoo Finance 17 Apr 2024

Institutional investors in Stryker Corporation (NYSE:SYK) lost 3.0% last week but have reaped the...

Key Insights Institutions' substantial holdings in Stryker implies that they have significant inf...

Simply Wall St. via Yahoo Finance 16 Apr 2024

Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition

Bio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma sp...

Zacks via Yahoo Finance 16 Apr 2024

Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?

Align Technology‘s ALGN shares have surged 20.5% year to date compared with the industry’s growth...

Zacks via Yahoo Finance 10 Apr 2024